Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

What side effects should we be concerned about from psychedelic treatments? - Neural Therapeutics

What side effects should we be concerned about from psychedelic treatments? - Neural Therapeutics

Neural Therapeutics Inc.' Scientific Advisor Professor David Nutt answers some of the questions raised by his recent presentation on the potentially revolutionary untapped effects of psychedelic medicine.

Today's questions is: Most studies have used healthy volunteers. What side effects should we be concerned about if we permit studies including veterans who may benefit but likely have multiple issues (E.g. drug or alcohol use disorders)?

The presentation itself focused on what Professor Nutt describes as the utility of psychedelic compounds and their potential to transform the treatment of mental illness.

Neural Therapeutics is a drug-discovery company focusing on plant-based active substances with the goal of delivering beneficial, over-the-counter dietary supplements and psychedelic-based therapeutic medicines to treat serious mental ailments where no significant treatment is available today.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK